![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 14/715 | |
C12N 15/12 | |||
A61K 38/17 | |||
A61P 35/00 | |||
A61K 38/00 | |||
C07K 14/705 |
(11) | Number of the document | 2657252 |
(13) | Kind of document | T |
(96) | European patent application number | 11851725.9 |
Date of filing the European patent application | 2011-12-21 | |
(97) | Date of publication of the European application | 2013-10-30 |
(45) | Date of publication and mention of the grant of the patent | 2017-03-08 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/KR2011/009914 |
Date | 2011-12-21 |
(87) | Number | WO 2012/087017 |
Date | 2012-06-28 |
(30) | Number | Date | Country code |
20100132955 | 2010-12-23 | KR |
(72) |
KIM, Sung Wuk, KR
JUN, Sung Soo, KR
PARK, Seung Kook, KR
KIM, Song Young, KR
KIM, Eun Sun, KR
JEONG, Jae Kap, KR
KIM, Ha Na, KR
SONG, Yeon Jung, KR
|
(73) |
HanAll Biopharma Co., Ltd.,
400-1 Sangseo-dong Daedeok-gu, Daejeon 306-120,
KR
|
(54) | MODIFIED HUMAN TUMOR NECROSIS FACTOR RECEPTOR-1 POLYPEPTIDE OR FRAGMENT THEREOF AND METHOD FOR PREPARING SAME |
MODIFIED HUMAN TUMOR NECROSIS FACTOR RECEPTOR-1 POLYPEPTIDE OR FRAGMENT THEREOF AND METHOD FOR PREPARING SAME |